Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization
about
Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.Familial risk of cancer and knowledge and use of genetic testing.A randomized, controlled trial to increase discussion of breast cancer in primary careEthical concerns related to developing pharmacogenomic treatment strategies for addiction.Development of a brochure for increasing awareness of inherited breast cancer in black women.Patient counseling increases postpartum follow-up in women with gestational diabetes mellitusWho is being referred to cancer genetic counseling? Characteristics of counselees and their referralPublic awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients.Molecular genetics to genomic medicine practice: at the heart of value-based delivery of healthcare.Mendelian genetics of rare--and not so rare--cancers.Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.Implementation of an electronic genomic and family health history tool in primary prenatal care.Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors.Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care
P2860
Q33703141-E595A780-14DA-4E1D-AD69-60053E578F8DQ33898716-37420700-30C2-4F38-A851-99B004D20820Q34202287-B2FF8312-77B6-4654-83E8-9CCF32DAD6AFQ35286480-A416F279-B7FD-417E-BB6E-2544C319930AQ36110695-DE9D1E2E-0ADE-438A-BAB5-46227B210AB0Q36182577-BE8ACEE4-D108-419F-8D6B-C5F011806D46Q36288206-2E50FC7F-C6A2-4A89-B1E4-22D7E8DC8A10Q36433665-BD73A010-3F05-435E-85B4-BA9F042DE125Q36595729-B6276665-B95B-467E-860A-A45FBC439F12Q36706640-2F03D026-9042-41EF-9F7E-C71F8EFAB427Q37237966-CD68662A-87C1-493A-9941-944C1BF91EE0Q37483881-FD0075A1-9E8A-48A4-94A5-4D96CF7938AEQ37800175-C8B2C0BE-8370-4763-9D28-F445CFC7E426Q37994638-49CB1F2E-33D2-49C2-B5FA-0396F6CE76B5Q39234236-468D059F-4EDD-4551-8771-ACFE4D49E503Q39361685-8B3D3311-2294-4764-B8F0-98FDF03543A5Q42430542-B48455BC-5D23-4F46-98D2-D68F4C1FA4DAQ45046740-0F3FE366-8577-4700-BE40-1228A7C3CEEDQ47109110-E39C4A0C-AC6D-4F53-9BB3-C711AF904339Q58786293-086C5ED1-D084-427A-AE84-72BE1AA4C8F4
P2860
Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidelines for genetic risk as ...... agreements and low utilization
@en
Guidelines for genetic risk as ...... greements and low utilization.
@nl
type
label
Guidelines for genetic risk as ...... agreements and low utilization
@en
Guidelines for genetic risk as ...... greements and low utilization.
@nl
prefLabel
Guidelines for genetic risk as ...... agreements and low utilization
@en
Guidelines for genetic risk as ...... greements and low utilization.
@nl
P2093
P2860
P1476
Guidelines for genetic risk as ...... agreements and low utilization
@en
P2093
Alexandra E Shields
Douglas E Levy
Judy E Garber
P2860
P2888
P304
P356
10.1007/S11606-009-1009-6
P577
2009-05-20T00:00:00Z